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Abstract: 
Dengue fever is a global disease with a spectrum of clinical manifestation ranging from mild 
febrile disease to a severe disease in the form of dengue hemorrhagic fever and dengue shock 
syndrome.  Dengue virus is one viral hemorrhagic fever that exists in the Kingdom of Saudi 
Arabia in addition to Alkhumra (Alkhurma) Hemorrhagic Fever, Chikungunya virus, Crimean–
Congo Hemorrhagic Fever, and Rift Valley Fever.  The disease is limited to the Western and 
South-western regions of Saudi Arabia where Aedes aegypti exists.  The majority of the cases in 
Saudi Arabia had mild disease and is related to serotypes 1-3 but not 4.  The prospect for Dengue 
virus control relies on vector control, health education and possibly vaccine use. Despite 
extensive collaborative efforts between multiple governmental sectors including Ministry of 
Health, Ministry of Municipalities and Rural Affairs, and Ministry of Water dengue remains a 
major public health concern in the regions affected. 
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Introduction: 
Dengue fever (DF) is a global disease with a spectrum of clinical manifestation ranging from 
mild febrile disease to a severe disease in the form of dengue hemorrhagic fever (DHF) and 
dengue shock syndrome (DSS).  According to the World Health Organization, severe dengue 
disease in suspected dengue patients is defined as the presence of any of severe plasma leakage 
that leads to shock (dengue shock) and/or fluid accumulation with respiratory distress; severe 
bleeding; or severe organ impairment (World Health Organization (WHO) 2012). 
Dengue infection occurs in an endemic form in 128 countries worldwide (Khetarpal & Khanna 
2016).  DF is one of several viral hemorrhagic fevers that exist in the Kingdom of Saudi Arabia 
(Alhaeli et al. 2016) in addition to Alkhumra (Alkhurma) Hemorrhagic Fever (AHF) (Zaki 1997; 
Al-Tawfiq & Memish 2017), Chikungunya Haemorrhagic Fever (Hussain et al. 2013), Crimean–
Congo Hemorrhagic Fever (CCHF) (Leblebicioglu et al. 2015; El-Azazy & Scrimgeour 1997; 
Hassanein et al. 1997), and Rift Valley Fever (RVF) (Balkhy & Memish 2003; Al-Afaleq & 
Hussein 2011).  Of the four serotypes of Dengue virus, serotypes 1-3 but not 4 were reported in 
Saudi Arabia (Ashshi 2017).  The first description of Dengue fever in Saudi Arabia dates back to 
1994 when Dengue virus serotype 2 (DEN-2) was isolated from a fatal and a non-fatal cases in 
Jeddah, Saudi Arabia (Fakeeh & Zaki 2001).   
Search strategy 
The search included MEDLINE and Scopus databases for articles published in English as 
follows: 
#1: “Dengue” OR “Dengue Virus” OR “Dengue Hemorrhagic Fever” OR “Dengue Fever” 
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#2: “Saudi Arabia” OR “Kingdom of Saudi Arabia”; 
#3: #1 AND #2. 
In addition, we searched the Saudi Epidemiology Bulletin (available from the Saudi Ministry of 
Health at: http://www.fetp.edu.sa/Bulletin.html ).   
The Virus: 
Dengue fever, DHF, and DSS are caused by the dengue viruses (DENV).  Dengue virus is a 
member of the genus Flavivirus, a member of the family Flaviviridae.  The genus Flavivirus is 
classified into two broad categories based on the vector of transmission: tick-borne viruses and 
mosquito-borne viruses (figure 1).  The Dengue virus is a mosquito-borne virus.  Four 
antigenically related but distinct dengue virus serotypes exist and are: dengue virus types 1–4 
(DENV-1, DENV-2, DENV-3, and DENV-4) (Khetarpal & Khanna 2016).  
Virus Transmission: 
The Dengue viruses are transmitted to humans by the females of the mosquito Aedes.  The most 
important vector is A. aegypti and other species such as A. albopictus, A. polynesiensis, and A. 
niveushave are secondary vectors (Malavige et al. 2004).  The virus is limited to the Western and 
South-western regions of Saudi Arabia (Fakeeh & Zaki 2001; El-Kafrawy et al. 2016; Ayyub et 
al. 2006; Khan et al. 2008; Al-Azraqi et al. 2013; Alhaeli et al. 2016). Four different Aedes 
species were identified in the Western part of Saudi Arabia (Alikhan et al. 2014; Abdullah & 
Merdan 1995; Jupp et al. 2002; Al Ahmad et al. 2011; Alahmed et al. 2009; Kheir et al. 2010; 
Aziz et al. 2012) and only A. caspius was identified in the Eastern Saudi Arabia (Wills et al. 
1985) (table 1).  In a case control study, the following factors were associated with the risk of 
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Dengue virus infection: presence of stagnant water (OR = 4.9), indoor larvae (OR = 2.2), 
construction sites (OR = 2.2), and older age (OR = 1.2) (Kholedi et al. 2012).  It is known that 
rain fall in Jeddah is low.  The occurrence of A. aegypti with Dengue fever in Jeddah is in 
paradox with the low level of rain; however, water containers play a role as breeding sites for A. 
aegypti (Ghaznawi et al. 1997; El-Gilany et al. 2010). In addition, the occurrence of huge 
constructions between 2008 and 2012 in Makkah, Saudi Arabia may had resulted in increased 
number of cases due to the formation of stagnant water (alwafi et al. 2013).     Moreover, Jeddah 
is the Hajj entry point and is the largest commercial port and airport welcoming many Pilgrims 
coming from Dengue High Disease Burden.  Thus in this context, the role of International Travel 
as the source of Dengue is a possibility. A recent study showed the role of visitors from dengue 
endemic countries in the importation of the virus into Saudi Arabia (Al-Saeed et al. 2017).  The 
study showed that all dengue viruses in 2010-2015 were from the circulating Indian subcontinent 
lineage of the Cosmopolitan genotype (Al-Saeed et al. 2017). 
Incidence: 
In Saudi Arabia, Dengue fever registry was made electronically in 2008 and Dengue is a 
notifiable disease in Saudi Arabia.  The incidence of DENV infection among tested patients 
varies based on the location, year of the study and the method of testing (table 2) (Ashshi 2017; 
Ashshi et al. 2017; Fakeeh & Zaki 2001; Khan et al. 2008; Al-Azraqi et al. 2013; Ayyub et al. 
2006; Organji et al. 2017; Shahin et al. 2009; Fakeeh & Zaki 2003; El-Gilany et al. 2010; alwafi 
et al. 2013; Gamil et al. 2014; Memish et al. 2011).  The number of DENV infection was 6512 
cases in 2013; 2081 cases in 2014; 4312 cases in 2015.  The number of cases varies between 425 
and 4312 per year (Alshamrani et al. n.d.; Organji et al. 2017).  The annual number of cases of 
Dengue virus n in Saudi Arabia is shown in figure 2 and the highest number of cases was in 
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2013, 2015, and 2016.  However, the overall prevalence of DENV is 40-48.7% among clinically 
suspected patients (Khan et al. 2008; Ayyub et al. 2006) and 31.7% among random sample of 
patients attending the outpatients' clinics (Al-Azraqi et al. 2013).  In a study from 2008 to 2012, 
the incidence rate doubled to 110 per 100,000 population in 2009 indicating the occurrence of an 
outbreak (alwafi et al. 2013).  The majority of affected patients are adults and infected children 
constituted 24% (Shahin et al. 2009) in one study and 6% in another study (Ayyub et al. 2006).  
In a recent study, the age-standardised incidence rates of dengue was 10-99 per 100 000 person-
years in 2013 (Stanaway et al. 2016). 
Seasonality 
In a study of 159 cases in Makkah, 77% of the cases were during the spring and early summer 
(Shahin et al. 2009).  And another study showed increased cases in the summer months and 
during the months of December and January (Kholedi et al. 2012).  In a study of 4187 cases, the 
peak cases occurred in April-May (alwafi et al. 2013) and a similar finding was in a report of 264 
cases from Jazan (Gamil et al. 2014) and a study of cases in 2013-2014 (Aziz, Salman Abdo Al-
Shami, et al. 2014).  Thus, the majority of cases occurred in April-May. 
Clinical Presentations: 
Dengue fever is characterized by constitutional findings of fever, severe headache, backache, 
joint pains, nausea and vomiting, eye pain and rash.  The disease affects all age groups but tends 
to cause milder disease in young children.  Dengue virus may cause one of four 
syndromes/diseases: undifferentiated fever, classic dengue fever, dengue hemorrhagic fever, or 
dengue shock syndrome.  The first 207 patients had mild Dengue fever and only one patient had 
dengue shock syndrome (DSS) and one had Dengue Hemorrhagic fever (DHF) (Fakeeh & Zaki 
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2001).  The affected patients in Saudi Arabia were more likely to be male and of young age 
group (summarized in table 3).   The signs of symptoms of Saudi patients with dengue infections 
are summarized in table 4 (Ayyub et al. 2006; Khan et al. 2008; El-Gilany et al. 2010; Shahin et 
al. 2009; Ahmed 2010; Badreddine et al. 2017).  The majority of patients (60-93%) presented 
with dengue fever, 5-39.4% had DHF, and about 1% had DSS.  The reported mortality was also 
low.  Dengue infection accounts for a total of 0.15-0.29 mortality per million person-years in 
Saudi Arabia in 2013 (Stanaway et al. 2016).  Men are more affected than women in the various 
included studies.  This is mainly related to the fact that men work outdoors and that women in 
Saudi wear clothing covering head to toes (alwafi et al. 2013). 
Geographic Distribution 
Dengue virus was mainly reported from the Western and South-western regions of Saudi Arabia 
(Fakeeh & Zaki 2001; El-Kafrawy et al. 2016; Ayyub et al. 2006; Khan et al. 2008; Al-Azraqi et 
al. 2013; Alhaeli et al. 2016).  This geographic restriction is directly related to the presence of A. 
aegypti  in the region (Alikhan et al. 2014; Jupp et al. 2002; Al Ahmad et al. 2011; Alahmed et 
al. 2009; Kheir et al. 2010; Aziz et al. 2012) and not in other parts of the Kingdom of Saudi 
Arabia  (Wills et al. 1985; Abdullah & Merdan 1995). Mathematical modelling showed that 
central Jeddah districts were the hotspots and the pattern changes greatly with time (Khormi et 
al. 2011).  Using modelling techniques, a total of 111 districts in Jeddah were investigated for the 
risk of Dengue fever (Khormi & Kumar 2012).  Of those districts, 15% were high risk, 22% were 
medium risk, 16% were low risk and 46% were very low risk (Khormi & Kumar 2012).  An 
analysis of 2288 cases of Dengue fever, the disease was found to be concentrated in the south 
and central-north regions of Jeddah, Saudi Arabia (Alzahrani et al. 2013). 
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Virus Serotypes: 
Dengue virus serotype is associated with the risk of DHF with highest risks with DENV-2, 
DENV-3, DENV-4 and DENV-1, as well as the pre-existence of anti-dengue antibodies.  In the 
initial study of 985 suspected cases, DEN-2 accounted for 138 (66.7%) of 207 isolates, DEN-1 
for 56 (27%), and DEN-3 for 13 (6.3%) (Fakeeh & Zaki 2001). The contribution of each 
serotype to Dengue in Saudi Arabia is shown in table 3.  However, DENV-4 was not reported in 
any of the studies based on serology and molecular testing (Fakeeh & Zaki 2001; Ayyub et al. 
2006; Khan et al. 2008; Organji et al. 2017; Fakeeh & Zaki 2003).  Phylogenetic analysis of 19 
isolates showed that DENV-1 and DENV-2 caused the 1994 outbreaks and it was an America-
Africa genotype (lineage India-2) (Zaki et al. 2008).  DENV-3 was isolated in 1997 and the 
outbreak in 2005-2006 was caused by a strain from genotype Asia (lineage Asia-2) (Zaki et al. 
2008).  Sequencing of the Dengue virus DENV-1-Jeddah-1-2011 strain showed high similarity 
with the Asian genotype (D1/H/IMTSSA/98/606 isolate) reported from Djibouti in 1998 (Azhar 
et al. 2015). 
Seroprevalence among asymptomatic individuals: 
The seroprevalence of Dengue virus antibodies among asymptomatic individuals was found to be 
47.8% (927/1939) and among blood donors was 37% (68/184) (Jamjoom et al. 2016).  The 
seroprevalence of anti-dengue IgG was 31.7% among asymptomatic persons attending outpatient 
clinics (Al-Azraqi et al. 2013).  In one study, male gender, older age and communal and multi-
story housing were significant factors for positive ELISA tests (Jamjoom et al. 2016).  In a 
seroprevalence study of 1024 soldiers, only 0.1% tested positive for DENV by ELISA (Memish 
et al. 2011).  Thus, there is variable seroprevalence of dengue among the different population 
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studied and is higher among patients attending outpatient clinics (31.7%) than the general 
population (0.1%).  The general population may also represent the different regions of the 
country which may not be dengue fever areas. 
Prospect for Control: 
Strategies to control Dengue virus requires the control of the vector, A. aegypti, through 
elimination of breeding sites and the elimination of the vector itself.  It is important to intensify 
the use of insecticides to control mosquito due to the quick and efficient knock-down activity 
(Aziz, Salman Abdo Al-Shami, et al. 2014).  In one study in Jazan, Saudi Arabia, A. aegypti 
mosquitoes were susceptible to Cyfluthrin and had variable resistances to other insecticides such 
as: ambda-cyhalothrin, Deltamethrin, Permethrin, Fenitrothion, Bendiocarb and DDT (Alsheikh 
et al. 2016). Health education and awareness of the disease and its vector play a major role in the 
control of Dengue in Saudi Arabia (Aziz, Salman A Al-Shami, et al. 2014).  In one study from 
Saudi Arabia, high students' knowledge score was associated with family history of Dengue 
fever, having literate mothers, and age > 17 years (Ibrahim et al. 2009).  Gambusia holbrooki fish 
was effective in domestic water containers to control A. aegypti (Gamal 2012).  In addition, the 
World Health Organization provides 36 boxes for the control of Dengue fever and includes 
Aedes control methods, Global Strategy for prevention and control of DF/DHF, and lessons 
learned from sustained efforts in countries combating dengue virus (Parks & Lloyd 2004).  One 
dengue virus vaccine was licensed in Latin America and Southeast Asia.  Two large phase III 
randomized controlled trials of this vaccine showed about 60% against virologically confirmed 
dengue in the first 13 months post-vaccine (Villar et al. 2015; Capeding et al. 2014).  In a meta-
analysis of nine studies, the vaccine efficacy was 54% with reduced efficacy of 34% for DENV2 
(Malisheni et al. 2017).  However, the vaccine was associated with higher relative risk of dengue 
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infection during the third year post-vaccination (Hadinegoro et al. 2015). The World Health 
Organization does not recommend the use of the vaccine for widespread vaccination nor for the 
use in areas with less than 50% seroprevalence (Anon 2016; World Health Organization 2017). 
Conclusion: 
Dengue fever in Saudi Arabia is limited to the Western and South-western regions of the country 
and is linked to Aedes aegypti.  The majority of the patients had mild disease and were caused by 
serotypes 1-3.  Despite extensive collaborative efforts between multiple governmental sectors 
including Ministry of Health, Ministry of Municipalities and Rural Affairs, and Ministry of 
Water, dengue remains a major public health concern in the regions affected.  The prospect for 
Dengue virus control relies on vector control, health education and possibly vaccine use. 
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Table 1: Aedes species according to the Region in Saudi Arabia 
Species Region Year Reference 
Aedes aegypti, Aedes 
arabiensis and Aedes 
caspius. 
Western 1956 (Alikhan et al. 2014) 
Aedes caspius Eastern 1985 (Wills et al. 1985) 
Aedes caspius South western 1995 (Abdullah & Merdan 
1995) 
Aedes vittatus Southern 2001 (Alikhan et al. 2014) 
Aedes vexans 
arabiensis, Aedes 
vittatus, Aedes 
caspius and Aedes 
caballus 
Jizan 2002 (Jupp et al. 2002) 
Aedes 
caspius and Aedes 
aegypti 
Jeddah 2011 (Al Ahmad et al. 
2011) 
Aedes aegypti, Aedes 
(Ochlerotatus) 
caspius, Aedes 
(Ochlerotatus) 
vexans var. arabiensis  
Jeddah 2014 (Alikhan et al. 2014) 
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Aedes caspius, 
A. aegypti and others 
Makkah 2004-2006 (Alahmed et al. 2009) 
Aedes caspius, 
A. aegypti and others 
Madinah 2010 (Kheir et al. 2010) 
co-breeding of Aedes, 
Culex and Anopheles 
Makkah 2008-2009 (Aziz et al. 2012) 
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Table 2: A Summary of the incidence of Dengue virus infection among tested patients based on the location, year of the study 
and the method of testing 
 
Study type Study 
population 
Method of 
detection 
Number 
included 
% positive Reference 
Cross sectional Male blood 
donors 
ELISA 910 39 IgG; 5.5 IgM (Ashshi 2017; 
Ashshi et al. 
2017) 
Longitudinal  Suspected cases Viral culture 985 21 (Fakeeh & Zaki 
2001) 
Longitudinal  Suspected cases ELISA 985 11 (Fakeeh & Zaki 
2001) 
Cross sectional random sample 
of patients 
attending the 
outpatients' 
ELISA 965 31.7 IgG (Al-Azraqi et al. 
2013) 
25 
 
clinics in Jizan 
and Aseer region 
Longitudinal 
April to July 
2004 
clinically 
suspected 
patients, Makkah 
ELISA and RT-
PCR 
160 40 (n=64) IgM 
ELISA, 8.7 
(n=14) by RT-
PCR and 8.1 (n 
=13) by both 
(Khan et al. 
2008) 
Longitudinal 
May 2004- April 
2005 
clinically 
suspected 
patients, Jeddah 
ELISA 80 48.7 (Ayyub et al. 
2006) 
NA clinically 
suspected 
patients, Makkah 
RT-PCR 25 24 (Organji et al. 
2017) 
Longitudinal 
2006 to 2008 
clinically 
suspected 
patients, Makkah 
ELISA or RT-
PCR 
159 100 (Shahin et al. 
2009) 
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Longitudinal 
1994 to 2002 
clinically 
suspected 
patients, Jeddah 
Virus isolation 
or ELISA 
1020 31.3 (of those 
65.5% by virus 
isolation and the 
rest were based 
on serology) 
(Fakeeh & Zaki 
2003) 
September to 
mid December 
in 2006 
Admitted 
patients, Makkah 
Virus isolation 
or ELISA 
71 100 (El-Gilany et al. 
2010) 
Longitudinal 
study 2008-
2012, Makkah 
Confirmed cases NA 4187 100 (alwafi et al. 
2013) 
Cross sectional 
April 2010-
March 2011, 
Jazan 
Suspected cases ELISA 553 47.7 (Gamil et al. 
2014) 
Cross sectional, Seroprevalence ELISA 1024 0.1 (Memish et al. 
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2009, Saudi 
military forces, 
Jazan 
2011) 
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Table 3: Summary of Characteristics of Confirmed Dengue Fever Cases in Saudi Arabia 
Number Study 
population 
Method 
of 
detection 
Serotype Age Male to 
Female 
ratio 
Reference 
91 clinically 
suspected 
patients, 
Makkah 
ELISA 
and RT-
PCR 
DENV-2: 19 
(20.8%)  
DENV-3: 4 
(4.3%) 
median 
age: 26 
(range=6-
94) 
1.5:1 (Khan et al. 
2008) 
39 clinically 
suspected 
patients, 
Jeddah 
ELISA  Range: 2-
60; mean 
27.6 + 
11.2 
3.3.:1 (Ayyub et al. 
2006) 
25 clinically 
suspected 
patients, 
Makkah 
RT-PCR DENV-1 
50% DENV-
2 33.3%; 
DENV-3: 
16.6% 
  (Organji et 
al. 2017) 
159 clinically 
suspected 
patients, 
Makkah 
ELISA or 
RT-PCR 
 25.6±16.1 
years 
(range 4 
to 81 
years) 
2:1 (Shahin et al. 
2009) 
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319 clinically 
suspected 
patients, 
Jeddah 
Virus 
culture or 
serology 
DENV-1: 
27% 
DENV-2: 
66% 
DENV-2: 6% 
adults 
between 
15-40 
years 
2.6:1 (Fakeeh & 
Zaki 2003) 
71 admitted to 
hospitals in 
Holly 
Makkah 
City, 2006 
(during the 
Hajj) 
Virus 
culture or 
serology 
 Adults 
16-44 
years 
1.7:1 (El-Gilany et 
al. 2010) 
4187 Confirmed 
cases 
reported to 
the Ministry 
of Health 
NA NA 47% 
between 
25 and 44 
years 
2.6:1 (alwafi et al. 
2013) 
264 Confirmed 
cases, Jazan 
ELISA NA 52% 
between 
15 and 44 
years 
 (Gamil et al. 
2014) 
19 Isolates in 
Jeddah 
RT-PCR DENV-1, 
DENV-2 and 
  (Zaki et al. 
2008) 
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DENV-3 
567 Cross 
sectional of 
confirmed 
cases 
RT-PCR 
in 29% 
Not reported 85% were 
adults 
2:1 (Badreddine 
et al. 2017) 
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Table 4: Signs and Symptoms of Patients with Dengue Fever, Numbers are percentage 
unless indicated otherwise 
 (Khan et 
al. 2008) 
(Ayyub 
et al. 
2006) 
(Shahin 
et al. 
2009) 
(El-
Gilany 
et al. 
2010) 
Total number 
of patients 
91 39 159 71 
Fever 100 100 100 100 
Malaise 83 66.7  67 
Musculoskeletal 81  100 59 
Headache 75 48.7 100 74 
Nausea 69 25.6 27 42.3 
Vomiting 65  27 39.4 
Abdominal pain 48  24.5 39.4 
Dengue fever 93  90 60.5 
DHF 7 5 10 39.4 
DSS 1  0.6  
Mortality  0 0.6 1.4 
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Figure 1: Genus Flavivirus and the Dengue Virus 
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Figure 2: Annual Number of Dengue Fever Cases in Saudi Arabia, Data from (Alshamrani 
et al. n.d.; Organji et al. 2017; Saudi Ministry of Health n.d.) 
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